CUSIP G1933S101ORD SHSCASIFQ4 2025
27 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Vr Adviser, LLC | 987.3K | $839.2K |
| 2 | Woodline Partners LP | 133.4K | $113.4K |
| 3 | Renaissance Technologies LLC | 43.1K | $36.6K |
| 4 | Two Sigma Investments, LP | 23.8K | $20.2K |
| 5 | Bank Of America Corp /De/ | 19.9K | $16.9K |
| 6 | Geode Capital Management, LLC | 18.8K | $16.0K |
| 7 | Citadel Advisors LLC | 14.0K | $11.9K |
| 8 | Royal Bank Of Canada | 9.9K | $8.0K |
| 9 |
| 4 | Jan 29, 2026 | Wei-Wu He, Ph.D. | 13D/A | 34.8% | — | SEC |
| 5 | Jan 20, 2026 | Idg-Accel China Growth Fund III L.P. | 13D/A | 4.8% | — | SEC |
| 6 | Jan 20, 2026 | Sparkle Byte Ltd | 13D/A | 5.0% | — | SEC |
| 7 | Jan 9, 2026 | Wei-Wu He, Ph.D. | 13D/A | 19.1% | — | SEC |
| 8 | Dec 18, 2025 | Wei-Wu He, Ph.D. | 13D/A | 19.1% | — | SEC |
| 9 | Dec 17, 2025 | Panacea Venture Healthcare Fund II, L.P. | 13D/A | 22.5% | — | SEC |
| 10 | Nov 26, 2025 | Chen Zhenfeng | 13G | 11.0% | 2.26M | SEC |
See the full Schedule 13D/13G history for Casi Pharmaceuticals Inc.
Unlock full history| Ubs Group AG |
| 659 |
| $560 |
| 10 | Wells Fargo & Company/Mn | 505 | $429 |